Drug Profile
Pneumococcal polysaccharide vaccine 23-valent - Shanxi Kangbao Biological Product
Alternative Names: 23-valent pneumococcal polysaccharide vaccine -Shanxi Kangbao Bilogical Product; Pneumococcal vaccine - Shanxi Kangbao Biological ProductLatest Information Update: 29 Aug 2023
Price :
$50
*
At a glance
- Originator Shanxi Kangbao Biological Product
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 29 Aug 2023 Discontinued - Preclinical for Pneumococcal infections in China (IM), prior to August 2023 (Shanxi Kangbao Biological Product pipeline, August 2023)
- 28 Feb 2020 No recent reports of development identified for preclinical development in Pneumococcal-infections in China (IM)
- 15 Jan 2016 Preclinical trials in Pneumococcal infections in China (IM)